ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,312, issued on Sept. 23, was assigned to Seagen Inc. (Bothell, Wash.).
"Anti-PD-L1 antibodies and antibody-drug conjugates" was invented by Byron Hua Kwan (Bothell, Wash.), Heather Van Epps (Bothell, Wash.), Andrew Waight (Bothell, Wash.), Scott Jeffrey (Snohomish, Wash.) and Ryan Lyski (Lynnwood, Wash.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are novel anti-PD-L1 antibodies and antibody-drug conjugates and methods of using such anti-PD-L1 antibodies and antibody-drug conjugates to treat cancer."
The patent was filed on Oct. 2, 2020, under Application No. 17/061,998.
*For further information, including images, charts and tables, pl...